S'abonner

A study on infectivity of asymptomatic SARS-CoV-2 carriers - 03/08/20

Doi : 10.1016/j.rmed.2020.106026 
Ming Gao a, 1 , Lihui Yang b, 1 , Xuefu Chen c , Yiyu Deng d , Shifang Yang e , Hanyi Xu e , Zixing Chen e , Xinglin Gao e,
a The Second School of Clinical Medicine, Southern Medical University, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510515, China 
b Hospital Infection Control Division, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China 
c Department of Infectious Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China 
d Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, 510080, China 
e Department of Respiratory and Critical Care Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial Geriatrics Institute, Guangzhou, 510080, China 

*Corresponding author. Department of Respiratory and Critical Care Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial Geriatrics Institute, 106 Zhongshan Er Road, Guangzhou, 510080, China.Department of Respiratory and Critical Care MedicineGuangdong Provincial People's HospitalGuangdong Academy of Medical SciencesGuangdong Provincial Geriatrics Institute106 Zhongshan Er RoadGuangzhou510080China

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

An ongoing outbreak of coronavirus disease 2019 (COVID-19) has spread around the world. It is debatable whether asymptomatic COVID-19 virus carriers are contagious. We report here a case of the asymptomatic patient and present clinical characteristics of 455 contacts, which aims to study the infectivity of asymptomatic carriers.

Material and methods

455 contacts who were exposed to the asymptomatic COVID-19 virus carrier became the subjects of our research. They were divided into three groups: 35 patients, 196 family members and 224 hospital staffs. We extracted their epidemiological information, clinical records, auxiliary examination results and therapeutic schedules.

Results

The median contact time for patients was four days and that for family members was five days. Cardiovascular disease accounted for 25% among original diseases of patients. Apart from hospital staffs, both patients and family members were isolated medically. During the quarantine, seven patients plus one family member appeared new respiratory symptoms, where fever was the most common one. The blood counts in most contacts were within a normal range. All CT images showed no sign of COVID-19 infection. No severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections was detected in 455 contacts by nucleic acid test.

Conclusion

In summary, all the 455 contacts were excluded from SARS-CoV-2 infection and we conclude that the infectivity of some asymptomatic SARS-CoV-2 carriers might be weak.

Le texte complet de cet article est disponible en PDF.

Highlights

An asymptomatic SARS-CoV-2 carrier of nosocomial infection was confirmed.
All the 455 contacts were excluded from SARS-CoV-2 infection.
Infectivity of some asymptomatic SARS-CoV-2 carriers was probably weak.

Le texte complet de cet article est disponible en PDF.

Keywords : SARS-CoV-2, Asymptomatic carrier, Contacts, Infectivity

Abbreviations : COVID-19, SARS-CoV-2, CHD, EDOU, ED, CT, RT-PCR, GCDC, CDC, IQR, PPE


Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 169

Article 106026- août 2020 Retour au numéro
Article précédent Article précédent
  • Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy
  • Yasuhiro Ito, Seiichi Miwa, Masahiro Shirai, Miho Kanai, Kaoru Fujita, Hisano Ohba, Eriko Iwaizumi, Tomoko Oshima, Suguru Kojima, Takafumi Suda, Hiroshi Hayakawa
| Article suivant Article suivant
  • Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy
  • Miia Aro, Tarja Saaresranta, Tero Vahlberg, Ulla Anttalainen

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.